Dr. Verma Discusses Clinical Trial Endpoints in Metastatic Breast Cancer
September 5th 2014
Sunil Verma, MD, MSEd, FRCPC, associate professor, University of Toronto, chair, Breast Medical Oncology, Sunnybrook Odette Cancer Centre, discusses targeting HER2 in early-stage breast cancer.